Cargando…
Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice
BACKGROUND: Mesenchymal stem cells (MSCs) have emerged as a promising cell-based therapy for acute kidney injury (AKI). However, the optimal route of MSC transplantation remains controversial, and there have been no comparisons of the therapeutic benefits of MSC administration through different deli...
Autores principales: | Huang, Mengjie, Li, Duo, Chen, Jianwen, Ji, Yuwei, Su, Tingyu, Chen, Yulan, Zhang, Yingjie, Wang, Yuanda, Li, Fei, Chen, Shang, Dong, Yu, Li, Qinggang, Wu, Lingling, Feng, Zhe, Wu, Jie, Zhang, Li, Li, Zongjin, Cai, Guangyan, Chen, Xiangmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953025/ https://www.ncbi.nlm.nih.gov/pubmed/35337372 http://dx.doi.org/10.1186/s13287-022-02805-3 |
Ejemplares similares
-
Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: a protocol for a randomised controlled trial
por: Yang, Yuanjun, et al.
Publicado: (2022) -
The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023) -
RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018) -
EGFR drives the progression of AKI to CKD through HIPK2 overexpression
por: Xu, Luyang, et al.
Publicado: (2019) -
Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)